E. Széll

430 total citations
15 papers, 342 citations indexed

About

E. Széll is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, E. Széll has authored 15 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in E. Széll's work include Chemical Synthesis and Analysis (8 papers), Peptidase Inhibition and Analysis (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). E. Széll is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Peptidase Inhibition and Analysis (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). E. Széll collaborates with scholars based in Hungary. E. Széll's co-authors include S. Bajusz, Éva Barabás, D Bagdy, Attila Juhász, Gyula Horváth, P Elödi, József I. Székely, Gy. Horváth and Gábor B. Makara and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and Biochemical Pharmacology.

In The Last Decade

E. Széll

11 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Széll Hungary 6 175 156 122 77 68 15 342
Donetta S. Gifford‐Moore United States 12 170 1.0× 100 0.6× 65 0.5× 149 1.9× 39 0.6× 20 364
Leonard C. Weir United States 7 232 1.3× 70 0.4× 122 1.0× 149 1.9× 31 0.5× 8 418
Douglas W. Beight United States 10 392 2.2× 41 0.3× 210 1.7× 143 1.9× 51 0.8× 15 616
Arie Visser Netherlands 9 113 0.6× 63 0.4× 24 0.2× 90 1.2× 36 0.5× 11 272
Mary Chou United States 10 117 0.7× 47 0.3× 93 0.8× 95 1.2× 127 1.9× 13 400
Brian L. Batley United States 11 311 1.8× 32 0.2× 87 0.7× 150 1.9× 41 0.6× 18 450
Susan G. Panzer‐Knodle United States 12 135 0.8× 259 1.7× 39 0.3× 60 0.8× 20 0.3× 18 561
Tawny K. Dahring United States 7 219 1.3× 28 0.2× 60 0.5× 93 1.2× 32 0.5× 7 318
Mark Edelstein United States 9 147 0.8× 55 0.4× 88 0.7× 27 0.4× 55 0.8× 27 321
Masahide Nakajima Japan 12 240 1.4× 20 0.1× 76 0.6× 88 1.1× 28 0.4× 28 438

Countries citing papers authored by E. Széll

Since Specialization
Citations

This map shows the geographic impact of E. Széll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Széll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Széll more than expected).

Fields of papers citing papers by E. Széll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Széll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Széll. The network helps show where E. Széll may publish in the future.

Co-authorship network of co-authors of E. Széll

This figure shows the co-authorship network connecting the top 25 collaborators of E. Széll. A scholar is included among the top collaborators of E. Széll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Széll. E. Széll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bajusz, S., et al.. (1995). Active site-directed thrombin inhibitors: α-hydroxyacylprolyl-arginals. New orally active stable analogs of d-Phe-Pro-Arg-H. Bioorganic & Medicinal Chemistry. 3(8). 1079–1089. 9 indexed citations
2.
Széll, E., et al.. (1995). Effect of peptide aldehydes with IL-1β converting enzyme inhibitory properties on IL-1α and IL-1β production in vitro. International Journal of Immunopharmacology. 17(12). 985–993. 5 indexed citations
3.
Barabás, Éva, E. Széll, & S. Bajusz. (1993). Screening for fibrinolysis inhibitory effect of synthetic thrombin inhibitors. Blood Coagulation & Fibrinolysis. 4(2). 243–248. 16 indexed citations
4.
Bagdy, D, Éva Barabás, S. Bajusz, & E. Széll. (1992). In Vitro Inhibition of Blood Coagulation by Tripeptide Aldehydes - A Retrospective Screening Study Focused on the Stable D-MePhe-Pro-Arg-H · H2SO4. Thrombosis and Haemostasis. 67(3). 325–330. 17 indexed citations
5.
Bagdy, D, et al.. (1992). In Vivo Anticoagulant and Antiplatelet Effect of D-Phe-Pro-Arg-H and D-MePhe-Pro-Arg-H. Thrombosis and Haemostasis. 67(3). 357–365. 26 indexed citations
6.
Bajusz, S., E. Széll, D Bagdy, et al.. (1990). Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H. Journal of Medicinal Chemistry. 33(6). 1729–1735. 141 indexed citations
7.
Bagdy, D, et al.. (1990). Pharmacodynamic effects and pharmacokinetics of D-MePhe-Pro-Arg-H.H2SO4 (GYKI-14766), a novel anticoagulant with antithrombotic properties. European Journal of Pharmacology. 183(5). 1835–1836. 1 indexed citations
9.
Bagdy, D, et al.. (1988). Experimental oral anticoagulation by a directly acting thrombin inhibitor (RGH-2958).. PubMed. 115(1-2). 136–40. 3 indexed citations
11.
Bajusz, S., et al.. (1987). Possible drugs labelled with 14C.IV.1 synthesis of D‐pheylalaninyl‐prolyl‐arginine aldehyde labelled in the guanidino group. Journal of Labelled Compounds and Radiopharmaceuticals. 24(6). 659–665.
12.
Széll, E., et al.. (1986). Specific inhibition of human granulocyte elastase with peptide aldehydes. FEBS Letters. 195(1-2). 265–268. 2 indexed citations
13.
14.
Bajusz, S., E. Széll, Éva Barabás, & D Bagdy. (1982). Design and synthesis of peptide inhibitors of blood coagulations.. PubMed. 109(1). 16–21. 2 indexed citations
15.
Bajusz, S., et al.. (1978). INHIBITION OF THROMBIN AND TRYPSIN BY TRIPEPTIDE ALDEHYDES. International journal of peptide & protein research. 12(4). 217–221. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026